Clinical Delivery Phosphorex positions as a drug-delivery focused CDMO capable of polymer and lipid nanoparticle platforms, custom microspheres, and bioconjugation services, with leadership expansion signaling growth and opportunities to partner with cell and gene therapy developers for delivery and imaging applications.

Custom Solutions Offers custom microspheres and surface-modified particles with bioconjugation support and encapsulation of customer-specified dyes or drugs, enabling co-development of tailored delivery vehicles for pharma and biotech clients.

Diagnostics Imaging A broad portfolio of fluorescent, phosphorescent, and color microspheres for ultra-sensitive assays, multiplex detection, and in vivo imaging presents opportunities to supply reagents and services to diagnostics labs, CROs, and research institutions.

Strategic Growth Backed by private equity and undergoing leadership enhancements, Phosphorex can leverage investor and industry networks to access new customers, collaborations, and strategic partnerships in the drug delivery and biotech space.

Market Readiness Small but specialized with a global tech stack and a focus on CDMO capabilities, Phosphorex has room to scale manufacturing for increasing demand in nanosphere/microsphere products across pharma, biotech, and academic markets.